Cullinan Oncology LLC Cash Flow-to-Debt Ratio
Cullinan Oncology LLC cash flow-to-debt ratio. Cullinan Oncology LLC (CGEM) has a Cash Flow-to-Debt Ratio of -1.25x as of March 2026, meaning its operating cash flow of $-46.05 Million could theoretically repay -1% of its total liabilities ($36.81 Million) in one year. Check Cullinan Oncology LLC cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cullinan Oncology LLC (2013–2025)
Cash flow-to-debt ratio of Cullinan Oncology LLC from 2013 to 2025. Historical debt coverage capacity for Cullinan Oncology LLC across 12 annual periods. Check CGEM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Cullinan Oncology LLC Cash Flow-to-Debt Ratio by Year (2013–2025)
Cullinan Oncology LLC cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Cullinan Oncology LLC. For the full cash flow conversion analysis, see cash efficiency ratio of Cullinan Oncology LLC.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.43x | $-175.75 Million | $39.64 Million | ▲ +3.9% |
| 2024 | -4.61x | $-145.30 Million | $31.50 Million | ▼ -4.1% |
| 2023 | -4.43x | $-134.28 Million | $30.29 Million | ▲ +8.7% |
| 2022 | -4.86x | $-126.66 Million | $26.09 Million | ▼ -32.0% |
| 2021 | -3.68x | $-43.43 Million | $11.81 Million | ▼ -77.8% |
| 2020 | -2.07x | $-29.77 Million | $14.39 Million | ▼ -1289.4% |
| 2019 | -0.15x | $-20.90 Million | $140.37 Million | ▲ +39.2% |
| 2018 | -0.25x | $-13.55 Million | $55.29 Million | ▲ +38.1% |
| 2016 | -0.40x | $-228.91K | $578.28K | ▼ -1950.7% |
| 2015 | -0.02x | $-24.03K | $1.24 Million | ▲ +75.8% |
| 2014 | -0.08x | $-91.72K | $1.15 Million | ▲ +88.6% |
| 2013 | -0.70x | $-718.41K | $1.03 Million | — |